Sakar Healthcare Limited
NSE:SAKAR.NS
309 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,541.673 | 1,333.59 | 1,282.267 | 947.393 | 829.802 | 682.493 | 530.765 | 441.708 | 412.26 | 350.273 | 296.852 | 219.069 |
| Cost of Revenue
| 842.088 | 735.466 | 748.143 | 514.934 | 437.984 | 356.943 | 282.838 | 222.851 | 219.676 | 173.328 | 132.278 | 84.6 |
| Gross Profit
| 699.585 | 598.124 | 534.124 | 432.46 | 391.819 | 325.551 | 247.927 | 218.857 | 192.584 | 176.945 | 164.574 | 134.469 |
| Gross Profit Ratio
| 0.454 | 0.449 | 0.417 | 0.456 | 0.472 | 0.477 | 0.467 | 0.495 | 0.467 | 0.505 | 0.554 | 0.614 |
| Reseach & Development Expenses
| 5.46 | 7.452 | 1.14 | 0.121 | 0.478 | 3.449 | 0.33 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 197.838 | 11.87 | 6.988 | 7.285 | 5.641 | 4.803 | 3.525 | 1.585 | 1.41 | 40.021 | 33.215 | 24.754 |
| Selling & Marketing Expenses
| 0.781 | 0.276 | 0.223 | 0.055 | 0.025 | 0.045 | 1.665 | 0.382 | 0.651 | 0.403 | 0.157 | 0.218 |
| SG&A
| 198.619 | 12.146 | 7.211 | 7.34 | 5.665 | 4.849 | 5.19 | 1.966 | 2.061 | 40.424 | 33.372 | 24.972 |
| Other Expenses
| -0.392 | 46.748 | 0.562 | 5.736 | 11.343 | 5.609 | 3.403 | 143.386 | 131.705 | 0 | 0 | 0 |
| Operating Expenses
| 204.079 | 416.562 | 328.501 | 286.939 | 267.126 | 216.158 | 165.696 | 145.352 | 133.766 | 123.79 | 107.823 | 79.089 |
| Operating Income
| 495.506 | 191.169 | 206.377 | 151.259 | 136.045 | 109.393 | 82.231 | 48.211 | 28.606 | 53.768 | 57.265 | 55.598 |
| Operating Income Ratio
| 0.321 | 0.143 | 0.161 | 0.16 | 0.164 | 0.16 | 0.155 | 0.109 | 0.069 | 0.154 | 0.193 | 0.254 |
| Total Other Income Expenses Net
| -336.509 | -21.257 | -16.298 | -18.932 | -13.776 | -12.199 | -21.139 | -25.294 | -30.211 | -29.599 | -37.227 | -37.798 |
| Income Before Tax
| 158.997 | 168.761 | 189.321 | 132.327 | 122.269 | 97.194 | 61.092 | 48.211 | 28.606 | 24.169 | 20.038 | 17.8 |
| Income Before Tax Ratio
| 0.103 | 0.127 | 0.148 | 0.14 | 0.147 | 0.142 | 0.115 | 0.109 | 0.069 | 0.069 | 0.068 | 0.081 |
| Income Tax Expense
| 42.288 | 41.175 | 37.522 | 25.502 | 26.041 | 27.083 | 22.945 | 14.428 | 6.427 | 5.804 | 2.519 | 3.349 |
| Net Income
| 116.709 | 127.586 | 152.425 | 106.825 | 96.228 | 70.11 | 38.147 | 33.783 | 22.179 | 18.365 | 17.519 | 14.451 |
| Net Income Ratio
| 0.076 | 0.096 | 0.119 | 0.113 | 0.116 | 0.103 | 0.072 | 0.076 | 0.054 | 0.052 | 0.059 | 0.066 |
| EPS
| 5.69 | 6.86 | 10.09 | 708.58 | 6.43 | 5.16 | 2.55 | 3.08 | 2.77 | 2.3 | 2.19 | 1.81 |
| EPS Diluted
| 5.69 | 6.86 | 10.09 | 708.58 | 6.43 | 5.16 | 2.55 | 3.08 | 2.77 | 2.3 | 2.19 | 1.81 |
| EBITDA
| 393.268 | 378.068 | 288.72 | 236.246 | 214.176 | 174.437 | 130.271 | 106.995 | 84.52 | 78.731 | 78.455 | 75.364 |
| EBITDA Ratio
| 0.255 | 0.283 | 0.225 | 0.249 | 0.258 | 0.256 | 0.245 | 0.242 | 0.205 | 0.225 | 0.264 | 0.344 |